Amedisys, Inc.
AMED
$94.14
-$0.13-0.14%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.35B | 2.32B | 2.29B | 2.25B | 2.24B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.35B | 2.32B | 2.29B | 2.25B | 2.24B |
| Cost of Revenue | 1.33B | 1.31B | 1.28B | 1.25B | 1.25B |
| Gross Profit | 1.02B | 1.01B | 1.01B | 999.37M | 990.87M |
| SG&A Expenses | 790.11M | 787.11M | 781.75M | 779.54M | 780.06M |
| Depreciation & Amortization | 18.00M | 17.57M | 17.24M | 17.58M | 17.75M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.14B | 2.11B | 2.08B | 2.05B | 2.04B |
| Operating Income | 209.57M | 208.93M | 209.12M | 202.25M | 193.07M |
| Income Before Tax | 86.22M | 134.64M | 143.60M | 32.14M | 39.62M |
| Income Tax Expenses | 48.05M | 51.94M | 51.80M | 53.39M | 50.56M |
| Earnings from Continuing Operations | 38.16 | 82.70 | 91.80 | -21.25 | -10.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.07M | 233.00K | 180.00K | 658.00K | 1.19M |
| Net Income | 43.23M | 82.93M | 91.98M | -20.59M | -9.75M |
| EBIT | 209.57M | 208.93M | 209.12M | 202.25M | 193.07M |
| EBITDA | 235.61M | 234.15M | 233.57M | 226.54M | 216.91M |
| EPS Basic | 1.32 | 2.54 | 2.82 | -0.64 | -0.30 |
| Normalized Basic EPS | 3.09 | 2.83 | 2.78 | 2.84 | 3.53 |
| EPS Diluted | 1.31 | 2.51 | 2.79 | -0.65 | -0.32 |
| Normalized Diluted EPS | 3.07 | 2.80 | 2.76 | 2.83 | 3.52 |
| Average Basic Shares Outstanding | 130.87M | 130.76M | 130.64M | 130.51M | 130.40M |
| Average Diluted Shares Outstanding | 131.91M | 132.07M | 131.77M | 131.30M | 130.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |